Allegri Lorenzo, Baldan Federica, Mio Catia, De Felice Mario, Amendola Elena, Damante Giuseppe
Department of "Area Medica", University of Udine, Udine, Italy.
Department of "Area Medica", University of Udine, Udine, Italy.
Eur J Med Genet. 2020 Jun;63(6):103894. doi: 10.1016/j.ejmg.2020.103894. Epub 2020 Feb 18.
Williams syndrome (WS) is a rare neurodevelopmental disorder associated to a hemizygous deletion of 28 genes located on chromosome 7q11.23. WS affected subjects frequently suffer from several endocrine abnormalities including hypothyroidism due to defects in thyroid morphology. To date, several genes involved in thyroid dysgenesis have been identified, nonetheless, none of them is located in the 7q11.23 region. Thus, the hypothyroidism-linked molecular features in WS are not yet known. In this study we focused on one of the WS deleted gene, BAZ1B, demonstrating that its downregulation in thyroid cells leads to cell viability and survival decrement. Taking together, our results show that BAZ1B could be the mainly responsible for thyroid defects observed in some of WS patients and that these alterations are activated by PTEN-mediated mechanisms.
威廉姆斯综合征(WS)是一种罕见的神经发育障碍,与位于7号染色体q11.23上的28个基因的半合子缺失有关。患有WS的受试者经常患有多种内分泌异常,包括由于甲状腺形态缺陷导致的甲状腺功能减退。迄今为止,已经鉴定出了几个参与甲状腺发育不全的基因,然而,它们都不在7q11.23区域。因此,WS中与甲状腺功能减退相关的分子特征尚不清楚。在这项研究中,我们聚焦于WS缺失基因之一BAZ1B,证明其在甲状腺细胞中的下调会导致细胞活力和存活率下降。综上所述,我们的结果表明,BAZ1B可能是一些WS患者中观察到的甲状腺缺陷的主要原因,并且这些改变是由PTEN介导的机制激活的。